Surprising FDA Reversal Allows Sarepta to Resume Gene Therapy Treatment On Monday afternoon, the FDA made a shocking reversal just…
Trending
- Senate committee rejects NIH cuts, boosts budget by $400 million
- New York City’s Best Omakase Sushi
- Carlyle Reportedly Buying Psychiatric Medical Care
- Trump administration launches health data sharing initiative
- Senators’ HHS budget leaves out RFK Jr.’s chronic disease agency
- Next on Kennedy’s List? Preventive Care and Vaccine Harm
- Study involving turquoise killifish pinpoints key mechanism of brain aging
- Nearly 70% of U.S. children in car crashes with a fatality were not using proper child passenger restraints, study finds